Heidi is the Senior Director of Program Management at GentiBio. She brings over 18 years of experience in the drug development space with extensive experience in program management for early and late-stage development platforms. Prior to joining GentiBio, Heidi was the Program Director at Dicerna Pharmaceuticals for Belcesiran, an alpha-1 antitrypsin liver disease program. Previously, Heidi was the Senior Director of Program Management for Eloxx Pharmaceuticals, which focuses on nonsense mutations in Cystic Fibrosis, Cystinosis and Inherited Retinal Disorders. During her career, she has been part of multiple global regulatory submissions, including the US approval of Tymlos at Radius Health. She has multiple publications in osteoporosis and fracture repair and holds several patents in bioanalytical method development. Heidi has a B.S. in Biology from Plymouth State University in New Hampshire.
In her spare time, Heidi enjoys skiing with her kids and coaching the Attitash Alpine Race Team in NH.